FLWPF (The Flowr) EBITDA Margin %: -107.09% (As of Sep. 2022)


What is The Flowr EBITDA Margin %?

The Flowr FLWPF -90.00% EBITDA Margin % is -107.09% as of Sep. 2022.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. The Flowr's EBITDA for the three months ended in Sep. 2022 was $-1.48 Mil. The Flowr's Revenue for the three months ended in Sep. 2022 was $1.38 Mil. Therefore, The Flowr's EBITDA margin for the quarter that ended in Sep. 2022 was -107.09%.

The Flowr  (OTCPK:FLWPF) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

The Flowr EBITDA Margin % Related Terms

The Flowr EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for The Flowr's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Flowr EBITDA Margin % Chart

The Flowr Annual Data
Trend Jun17 Jun18 Dec19 Dec20 Dec21
EBITDA Margin %
0.00 0.00 -648.33 -1,639.44 -625.65

The Flowr Quarterly Data
Sep17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -172.31 -1,537.67 -125.70 -642.92 -107.09

FLWPF vs ZTS, CTLT, VTRS: EBITDA Margin % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, The Flowr's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Flowr EBITDA Margin % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, The Flowr's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where The Flowr's EBITDA Margin % falls into.


The Flowr EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

The Flowr's EBITDA Margin % for the fiscal year that ended in Dec. 2021 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2021 )/Revenue (A: Dec. 2021 )
=-60.356/9.647
=-625.65 %

The Flowr's EBITDA Margin % for the quarter that ended in Sep. 2022 is calculated as

EBITDA Margin %=EBITDA (Q: Sep. 2022 )/Revenue (Q: Sep. 2022 )
=-1.48/1.382
=-107.09 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -107.09% mean?
The Flowr (FLWPF) has a EBITDA Margin % of -107.09% as of Sep. 2022. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on The Flowr and its competitors.
Is The Flowr's EBITDA Margin % too high?
The Flowr's current EBITDA Margin % is -107.09%.
How does The Flowr's EBITDA Margin % compare to ZTS and CTLT?
The Flowr's EBITDA Margin % of -107.09% can be compared against companies in the Drug Manufacturers industry. The industry median EBITDA Margin % is 12.49. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Drug Manufacturers company?
The median EBITDA Margin % among Drug Manufacturers companies is 12.49, based on 961 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on The Flowr and its competitors. For the Drug Manufacturers industry, the median EBITDA Margin % is 12.49 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. The Flowr's current EBITDA Margin % is -107.09%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Flowr stock overvalued right now?
The Flowr (FLWPF) has a current EBITDA Margin % of -107.09%. The current EBITDA Margin % is -107.09%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For The Flowr (FLWPF), the current EBITDA Margin % is -107.09% as of Sep. 2022. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

The Flowr Business Description

Address 365 Bay Street, Suite 800, Toronto, ON, CAN, M5H 2V1
The Flowr Corp is a Toronto-headquartered cannabis company with operations in Canada and Europe. Its Canadian operating campus, located in Kelowna, BC, includes a purpose-built, GMP-designed indoor cultivation facility; an outdoor and greenhouse cultivation site; and a R&D facility that is awaiting licensing from Health Canada. From this campus, Flowr produces recreational and medicinal products. Internationally, it intends to service the global medical cannabis market through its subsidiary Holigen, which has a license for cannabis cultivation in Portugal and operates GMP licensed facilities in Portugal.